North Run Capital’s Sanara MedTech SMTI Stock Holding History

North Run Capital’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.09M	Hold	24,000	–	–	2.51%	14
2022 Q3	$713K	Hold	24,000	–	–	1.45%	18
2022 Q2	$501K	Hold	24,000	–	–	1.03%	21
2022 Q1	$684K	Sell	24,000 -41,000	-63%	-$1.04M	1.01%	20
2021 Q4	$1.92M	Buy	65,000 +8,811	+16%	+$277K	1.48%	18
2021 Q3	$1.93M	Buy	56,189 +28,126	+100%	+$1.01M	1.39%	18
2021 Q2	$1.04M	Buy	+28,063	New	+$820K	0.71%	18

Other funds holding SMTI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SIC

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

North Run Capital's SMTI Position: Q4 2022 in Review

North Run Capital held its Sanara MedTech (SMTI) position steady in Q4 2022 at 24,000 shares worth $1.09M. The position accounts for 2.51% of the portfolio, ranked #14.

North Run Capital first reported a position in SMTI in Q2 2021 and has held it in 7 quarters since. The position peaked at $1.93M in Q3 2021. 31 funds tracked by Wall St. Rank hold SMTI as of Q4 2022.

North Run Capital held 24,000 shares of Sanara MedTech worth $1.09M as of Q4 2022.
North Run Capital left its Sanara MedTech share count unchanged in Q4 2022.
Sanara MedTech made up 2.51% of North Run Capital's portfolio in Q4 2022, its #14 holding.
North Run Capital first reported a position in Sanara MedTech in Q2 2021 and has held it in 7 quarters since.
North Run Capital's Sanara MedTech position peaked at $1.93M in Q3 2021.
31 funds tracked by Wall St. Rank held Sanara MedTech as of Q4 2022.

Based on North Run Capital's 13F filing for Q4 2022, filed 14 Feb 2023.